Floatz logo

Perifosine

Adult Acute Myeloblastic Leukemia With Maturation (M2)

National Cancer Institute (NCI)Small moleculePhase 1Dormant
CC
47/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
32/ 100
Competitive Position
95/ 100

Competitive context

0 Active assets in the Adult Acute Myeloblastic Leukemia With Maturation (M2) cohort.

Asset / SponsorPhaseRating
ETOPOSIDE
Stanford University
Phase 3BBB
Cytosin-Arabinosid
Northwestern University
Phase 3BBB
Daunorubicin
National Cancer Institute (NCI)
Phase 3BBB
Cyclophosphamide
ECOG-ACRIN Cancer Research Group
Phase 3BBB
Cytosin-Arabinosid
University of Southern California
Phase 3BBB

View all 50 →

Same molecule, other indications

Perifosine is also rated in:

renal cell carcinomaDormant
B
Indicative ·
61 / 100
View asset →
anaplastic astrocytomaDormant
B
Indicative ·
60 / 100
View asset →
plasma cell myelomaDormant
B
Indicative ·
60 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →